Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Heidi Hatledal Henanger"'
Autor:
Sigurd Ørstavik, Heidi Hatledal Henanger, Tilahun T. Hafte, Ane Funderud, Anne-Katrine Kvissel, Sissel Eikvar, Anja Camilla Larsen, Bjørn Steen Skålhegg
Publikováno v:
Current Drug Targets. 6:655-664
In several cases of immunodeficiency and autoimmunity, the dysfunctional immune system is associated with either hypo- or hyperactive T and B cells. In autoimmune conditions such as systemic lupus erythematosus (SLE) and immunodeficiencies such as ac
Autor:
Ellen Skarpen, Anne-Katrine Kvissel, Heidi Hatledal Henanger, Bjørn Steen Skålhegg, Ane Funderud, Henrik S. Huitfeldt, Sigurd Ørstavik, Morten P. Oksvold
Publikováno v:
BMC Cell Biology
BMC Cell Biology, Vol 9, Iss 1, p 16 (2008)
BMC Cell Biology, Vol 9, Iss 1, p 16 (2008)
Background Epidermal Growth Factor Receptor (EGFR) is a key target molecule in current treatment of several neoplastic diseases. Hence, in order to develop and improve current drugs targeting EGFR signalling, an accurate understanding of how this sig
Autor:
Sigurd Ørstavik, Tilahun T. Hafte, Paul S. Amieux, Ane Funderud, Heidi Hatledal Henanger, Bjørn Steen Skålhegg
Publikováno v:
BMC Biochemistry, Vol 7, Iss 1, p 20 (2006)
BMC Biochemistry
BMC Biochemistry
Background Two main genes encoding the catalytic subunits Cα and Cβ of cyclic AMP dependent protein kinase (PKA) have been identified in all vertebrates examined. The murine, bovine and human Cβ genes encode several splice variants, including the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1750817736e38e3db3d1827b99c9a0c
http://hdl.handle.net/10852/46652
http://hdl.handle.net/10852/46652